Marit Synnestvedt Selected Research

Therapeutics

1/2017	Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer.
1/2013	Combined analysis of vascular invasion, grade, HER2 and Ki67 expression identifies early breast cancer patients with questionable benefit of systemic adjuvant therapy.
4/2008	Vascularization in primary breast carcinomas: its prognostic significance and relationship with tumor cell dissemination.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marit Synnestvedt Research Topics

Disease

9	Breast Neoplasms (Breast Cancer) 01/2021 - 04/2008
7	Neoplasms (Cancer) 01/2017 - 09/2007
1	Neoplasm Metastasis (Metastasis) 01/2017

Drug/Important Bio-Agent (IBA)

2	Docetaxel (Taxotere)FDA Link 12/2014 - 07/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2012 - 02/2011
2	Phenobarbital (Luminal)FDA Link 02/2011 - 09/2007
1	4-hydroxy-N-desmethyltamoxifenIBA 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	Tamoxifen FDA LinkGeneric 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Fluorouracil (Carac)FDA LinkGeneric 12/2014
1	Epirubicin (Ellence)FDA LinkGeneric 12/2014
1	Biomarkers (Surrogate Marker)IBA 12/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2014
1	Messenger RNA (mRNA)IBA 07/2014
1	Mammaglobin AIBA 07/2014
1	Keratin-19 (Keratin 19)IBA 07/2014
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2012
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2012
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2012
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 09/2012
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 09/2012
1	Indicators and Reagents (Reagents)IBA 05/2011
1	AntibodiesIBA 02/2011
1	Hormones (Hormone)IBA 02/2011
1	Keratins (Keratin)IBA 02/2011

Therapy/Procedure

3	Therapeutics 01/2017 - 04/2008
1	Drug Therapy (Chemotherapy) 12/2014